Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up since Sep 25 · below the Ichimoku cloud · RSI 42 · MACD below its signal · 9% above its 52-week low
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $1.5M | 0.00% | 425.80K | −10% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SIGA trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.7 | -3.4 | -17.3 | -14.0 | 1.7 | -22.2 | -10.2 | -4.0 | 8.3 | -9.3 | −49.5% | ||
| 2025 | -0.5 | -8.2 | -0.2 | 0.7 | 8.3 | 9.0 | 1.4 | 26.9 | 9.1 | -9.5 | -26.8 | 0.8 | +1.7% |
| 2024 | -12.9 | 6.8 | 64.3 | 2.6 | -14.8 | 1.5 | 31.5 | -9.5 | -25.2 | 7.0 | 0.8 | -17.4 | +7.3% |
| 2023 | -0.4 | -6.5 | -16.1 | 1.4 | -3.8 | -10.0 | 13.7 | -20.0 | 14.4 | -2.9 | 6.5 | 3.1 | −23.9% |
| 2022 | -13.4 | -7.8 | 18.2 | -3.1 | 59.2 | 5.9 | 48.4 | -12.3 | -31.7 | -10.8 | -0.1 | -19.8 | −2.1% |
| 2021 | -11.1 | -2.2 | 2.8 | 10.3 | -1.7 | -10.9 | 1.4 | 2.5 | 13.2 | -2.4 | 13.2 | -7.8 | +3.4% |
| 2020 | 8.0 | -2.9 | -4.4 | 23.6 | 1.4 | -1.3 | 8.6 | 8.3 | -1.2 | -7.0 | 8.5 | 4.9 | +52.4% |
| 2019 | -14.2 | 0.0 | -11.4 | -12.8 | 1.9 | 6.4 | -1.4 | -10.4 | 2.0 | 8.4 | -11.7 | -2.7 | −39.6% |
| 2018 | 3.7 | 31.2 | -7.1 | -3.9 | 13.9 | -11.5 | 27.8 | 8.4 | -16.3 | -29.9 | 29.2 | 26.6 | +62.9% |
| 2017 | 3.1 | 10.8 | -4.6 | 18.2 | -7.0 | -11.9 | 4.3 | -4.4 | 4.6 | 51.4 | -0.2 | 1.3 | +68.4% |
| 2016 | 11.9 | 44.7 | -22.1 | 88.7 | -16.0 | 19.0 | 129.0 | 11.8 | 16.8 | -25.4 | 17.5 | 9.9 | +585.7% |
| 2015 | -2.1 | 61.0 | -14.5 | -8.8 | 4.5 | -30.3 | -8.5 | 14.4 | -12.6 | -36.4 | -13.3 | -35.4 | −70.8% |
| 2014 | 1.2 | -3.0 | -3.4 | -7.4 | -7.0 | 5.6 | -6.4 | -48.9 | 7.4 | -2.8 | 20.6 | -15.3 | −56.0% |
| 2013 | 11.5 | 46.6 | -16.4 | -7.8 | 13.0 | -23.9 | 12.3 | 10.7 | 8.2 | -10.2 | 2.9 | -7.4 | +24.8% |
| 2012 | 31.3 | -13.9 | 17.9 | -1.8 | -30.0 | 23.8 | 1.7 | 1.7 | 8.1 | -9.4 | -6.9 | -3.0 | +4.0% |
| 2011 | -18.0 | 16.7 | -9.7 | 13.5 | 1.5 | -30.1 | -21.9 | -24.6 | -43.0 | -0.9 | -35.2 | 20.0 | −82.0% |
| 2010 | 7.6 | 6.1 | 0.2 | 3.6 | 1.2 | 10.8 | 8.8 | -10.5 | 12.8 | 56.6 | -4.9 | 11.1 | +141.4% |
| 2009 | 23.5 | 20.8 | 3.9 | 22.3 | 17.6 | 15.8 | -7.8 | -5.9 | 7.8 | -19.1 | 41.8 | -35.9 | +77.4% |
| 2008 | -31.8 | 9.5 | 0.0 | 48.3 | -11.7 | 3.7 | -5.8 | 24.1 | 2.7 | -12.3 | -31.0 | 44.1 | +6.2% |
| 2007 | 0.0 | 5.6 | 22.0 | -6.4 | -16.6 | -12.7 | -10.3 | 31.9 | 2.8 | 0.8 | -13.4 | -11.7 | −17.9% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Durnan Jaymie A.Director | — | 24.1K | — |
| Jun 8, 2026 | Keane John MDirector | — | 24.1K | — |
| Jun 8, 2026 | Marshall Joseph W. IiiDirector | — | 24.1K | — |
| Jun 8, 2026 | Ford Harold Eugene JrDirector | — | 24.1K | — |
| Jun 8, 2026 | Nemirovsky JulianDirector | — | 24.1K | — |
| Jun 8, 2026 | Phillips Holly L.Director | — | 24.1K | — |
| Jun 8, 2026 | Nabel Gary J.Director | — | 24.1K | — |
| Mar 24, 2026 | Miller Larry R.General Counsel | — | 6.9K | — |
| Mar 12, 2026 | Hruby Dennis EOfficer | — | 11.4K | — |
| Mar 12, 2026 | Luckshire Daniel JChief Financial Officer | — | 11.5K | — |
| Mar 12, 2026 | Nguyen DiemChief Executive Officer | — | 85K | — |
| Mar 12, 2026 | Miller Larry R.General Counsel | — | 21.3K | — |
| Jan 26, 2026 | Nguyen DiemChief Executive Officer | — | 55.9K | — |
| Jun 30, 2025 | Hruby Dennis EOfficer | — | 32.3K | — |
| Jun 30, 2025 | Luckshire Daniel JChief Financial Officer | — | 24.2K | — |
| Jun 9, 2025 | Durnan Jaymie A.Director | — | 19.1K | — |
| Jun 9, 2025 | Marshall Joseph W. IiiDirector | — | 19.1K | — |
| Jun 9, 2025 | Ford Harold Eugene JrDirector | — | 19.1K | — |
| Jun 9, 2025 | Nemirovsky JulianDirector | — | 19.1K | — |
| Jun 9, 2025 | Phillips Holly L.Director | — | 19.1K | — |
No analyst coverage for this instrument.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.